Abstract
Scientists have tried for many years to understand cancer development and progression in the expectation of defining the therapeutic target. Emerging evidence has revealed that cancers contain a minority population, termed “Cancer stem cells (CSCs)”, which are responsible for sustaining the tumour as well as giving rise to proliferating cells. CSCs are thought share the three features with normal stem cells: self-renewal, the capability give rise to multiple lineages, the potential to proliferate extensively and therefore it has been proposed that they have their origin in normal stem cells. However, since there is evidence that genetic alterations occurring in committed progenitor cells can reactive their proliferative potential, the origin of CSCs still remains undecided. In this review, we discuss the current status of cancer stem cells in various tissues, the origin of some cancers from normal stem cells, the evidence for the existence of particular markers and aspects of their cell biology. Better understanding of the relation between adult stem cells and cancer stem cells in tumourigenesis may will provide novel therapeutic strategies against cancers.
Keywords: Stem cells, cancer stem cells, side population (SP), non-SP, tumourigenesis, mitochondria
Current Cancer Therapy Reviews
Title: Cancer and Stem Cells
Volume: 4 Issue: 3
Author(s): Lydia Gutierrez-Gonzalez, Osamu Inatomi, Julia Burkert and Nichoals A. Wright
Affiliation:
Keywords: Stem cells, cancer stem cells, side population (SP), non-SP, tumourigenesis, mitochondria
Abstract: Scientists have tried for many years to understand cancer development and progression in the expectation of defining the therapeutic target. Emerging evidence has revealed that cancers contain a minority population, termed “Cancer stem cells (CSCs)”, which are responsible for sustaining the tumour as well as giving rise to proliferating cells. CSCs are thought share the three features with normal stem cells: self-renewal, the capability give rise to multiple lineages, the potential to proliferate extensively and therefore it has been proposed that they have their origin in normal stem cells. However, since there is evidence that genetic alterations occurring in committed progenitor cells can reactive their proliferative potential, the origin of CSCs still remains undecided. In this review, we discuss the current status of cancer stem cells in various tissues, the origin of some cancers from normal stem cells, the evidence for the existence of particular markers and aspects of their cell biology. Better understanding of the relation between adult stem cells and cancer stem cells in tumourigenesis may will provide novel therapeutic strategies against cancers.
Export Options
About this article
Cite this article as:
Gutierrez-Gonzalez Lydia, Inatomi Osamu, Burkert Julia and Wright A. Nichoals, Cancer and Stem Cells, Current Cancer Therapy Reviews 2008; 4 (3) . https://dx.doi.org/10.2174/157339408785294249
DOI https://dx.doi.org/10.2174/157339408785294249 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intestinal Targeting of Drugs: Rational Design Approaches and Challenges
Current Topics in Medicinal Chemistry Endothelial Cell Targeted Molecular Imaging in Tumor Angiogenesis: Strategies and Current Status
Current Pharmaceutical Biotechnology Imaging Studies in Hypercalcemia
Current Medicinal Chemistry The Therapeutic Value of Natural Agents to Treat miRNA Targeted Breast Cancer in African-American and Caucasian-American Women
Current Drug Targets Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis
Current Neuropharmacology Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities
Current Cancer Drug Targets Optimization of Performance Variables of Exemestane Nanosuspension Using Box-Behnken Design to Improve Dissolution and Oral Bioavailability
Current Drug Delivery Technology Whitespaces India Should Focus: A Comparative Anti-Cancer Patent Rational Analysis of Indian and International Public Funded Universities
Recent Patents on Anti-Cancer Drug Discovery Clinical Management of Infectious Diarrhea
Reviews on Recent Clinical Trials Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells
Current Stem Cell Research & Therapy Network Medicine and High Throughput Screening
Current Drug Discovery Technologies Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
Current Aging Science Preparation, Characterization and <i>In Vitro</i> Biological Evaluation of Novel Curcumin Derivatives as Cytotoxic and Apoptosis-Inducing Agents
Anti-Cancer Agents in Medicinal Chemistry Actinium-225 in Targeted Alpha-Particle Therapeutic Applications
Current Radiopharmaceuticals Potential Usage of ING Family Members in Cancer Diagnostics and Molecular Therapy
Current Drug Targets Estrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in the Aging Blood Vessels
Current Medicinal Chemistry Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents
Anti-Cancer Agents in Medicinal Chemistry Transendothelial Migration of Monocytes: The Underlying Molecular Mechanisms and Consequences of HIV-1 Infection
Current HIV Research Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions
Current Molecular Medicine